Radius Pharmaceuticals Appoints Renata Sklodowska, M.D. as Senior VP of Medical Operations

Radius Pharmaceuticals, Inc., a subsidiary of Radius Health, Inc., announced the appointment of Renata Sklodowska, M.D. as Senior Vice President of Medical Operations. With over fifteen years of experience in clinical development, regulatory, and medical affairs, Dr. Sklodowska will report to CEO Scott Briggs and oversee Medical Operations, including Medical Affairs, Regulatory Affairs, and Pharmacovigilance (PV).

Scott Briggs expressed his enthusiasm, highlighting Dr. Sklodowska's extensive experience and leadership track record. He emphasized her patient-focused approach and ability to build alliances to support Radius' key products, TYMLOS® and BINOSTO®.

Dr. Sklodowska brings a wealth of expertise, especially in rare diseases and endocrinology, with a proven history in product launches and portfolio management. Her role will include providing scientific and medical guidance to support business development efforts at Radius.

Excited about her new position, Dr. Sklodowska aims to build on Radius' successes and expand its portfolio. She has previously held leadership roles at F2G and Recordati Rare Diseases and holds a Doctor of Medicine degree from the Medical University of Bialystok, Poland.